Fate Therapeutics Statistics
Total Valuation
FATE has a market cap or net worth of $160.56 million. The enterprise value is $95.92 million.
| Market Cap | 160.56M |
| Enterprise Value | 95.92M |
Important Dates
The last earnings date was Thursday, November 5, 2026, before market open.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FATE has 119.82 million shares outstanding. The number of shares has increased by 2.04% in one year.
| Current Share Class | 119.82M |
| Shares Outstanding | 119.82M |
| Shares Change (YoY) | +2.04% |
| Shares Change (QoQ) | +2.71% |
| Owned by Insiders (%) | 1.00% |
| Owned by Institutions (%) | 58.44% |
| Float | 105.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 33.68 |
| Forward PS | 79.92 |
| PB Ratio | 1.22 |
| P/TBV Ratio | 1.20 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.56.
| Current Ratio | 4.41 |
| Quick Ratio | 4.27 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.79% and return on invested capital (ROIC) is -31.20%.
| Return on Equity (ROE) | -67.79% |
| Return on Assets (ROA) | -27.92% |
| Return on Invested Capital (ROIC) | -31.20% |
| Return on Capital Employed (ROCE) | -63.24% |
| Weighted Average Cost of Capital (WACC) | 12.90% |
| Revenue Per Employee | $29,503 |
| Profits Per Employee | -$772,876 |
| Employee Count | 161 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.64% in the last 52 weeks. The beta is 2.67, so FATE's price volatility has been higher than the market average.
| Beta (5Y) | 2.67 |
| 52-Week Price Change | +19.64% |
| 50-Day Moving Average | 2.18 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 24.63 |
| Average Volume (20 Days) | 1,562,676 |
Short Selling Information
The latest short interest is 10.62 million, so 8.86% of the outstanding shares have been sold short.
| Short Interest | 10.62M |
| Short Previous Month | 10.76M |
| Short % of Shares Out | 8.86% |
| Short % of Float | 10.04% |
| Short Ratio (days to cover) | 6.60 |
Income Statement
In the last 12 months, FATE had revenue of $4.75 million and -$124.43 million in losses. Loss per share was -$1.03.
| Revenue | 4.75M |
| Gross Profit | -87.15M |
| Operating Income | -130.00M |
| Pretax Income | -124.43M |
| Net Income | -124.43M |
| EBITDA | -118.56M |
| EBIT | -130.00M |
| Loss Per Share | -$1.03 |
Balance Sheet
The company has $139.13 million in cash and $74.49 million in debt, with a net cash position of $64.64 million or $0.54 per share.
| Cash & Cash Equivalents | 139.13M |
| Total Debt | 74.49M |
| Net Cash | 64.64M |
| Net Cash Per Share | $0.54 |
| Equity (Book Value) | 133.03M |
| Book Value Per Share | 1.09 |
| Working Capital | 111.57M |
Cash Flow
In the last 12 months, operating cash flow was -$105.46 million and capital expenditures -$1.51 million, giving a free cash flow of -$106.97 million.
| Operating Cash Flow | -105.46M |
| Capital Expenditures | -1.51M |
| Depreciation & Amortization | 11.44M |
| Net Borrowing | n/a |
| Free Cash Flow | -106.97M |
| FCF Per Share | -$0.89 |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,736.88% |
| Pretax Margin | -2,619.64% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FATE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.04% |
| Shareholder Yield | -2.04% |
| Earnings Yield | -76.84% |
| FCF Yield | -66.88% |
Analyst Forecast
The average price target for FATE is $5.72, which is 327.02% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.72 |
| Price Target Difference | 327.02% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | -10.22% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |